ESC 365 - Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - PRO

HFA Premium Access

Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - PRO

Session: GRAND DEBATE I - Drugs or interventions - The beat goes on

Topic: Treatment, Other

Speaker: Professor J. Cleland (Glasgow, GB)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

82 presentations

13 followers

15 more presentations in this session

Positioning of the topic

Speaker: Professor E. Braunwald (Boston, US)

Opening question

Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - CONTRA

Speaker: Professor E. Velazquez (New Haven, US)

Rebuttal - PRO

Rebuttal - CONTRA

Access the full session

GRAND DEBATE I - Drugs or interventions - The beat goes on

Speakers: Professor J. Cleland, Professor E. Braunwald, Professor E. Velazquez

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources